Harnessing Disseminated PDX Models to Advance Drug Discovery for Hematologic Cancers
Time: 9:10 am
day: Day Two
Details:
• Understanding how disease progresses in different tissues in disseminated models
• Recapitulating the bone marrow niche ex vivo to inform in vivo study design
• Employing PDX models to identify clinically actionable combinations
Speakers:
Courtney Andersen is a Senior Scientist in the In Vivo Bioscience group at AstraZeneca in Boston. In her current role, Courtney supports oncology drug discovery programs and is a core member of the preclinical combinations team. She has experience with various in vivo tumor models, including disseminated patient-derived xenograft models, and ex vivo culture systems.…Read more